National Academies Press: OpenBook

Direct-to-Consumer Genetic Testing: Summary of a Workshop (2011)

Chapter: Appendix A: Glossary Of Terms And Acronyms

« Previous: Appendixes
Suggested Citation:"Appendix A: Glossary Of Terms And Acronyms." Institute of Medicine and National Research Council. 2011. Direct-to-Consumer Genetic Testing: Summary of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/13021.
×

Appendix A
Glossary Of Terms And Acronyms

allele. Any one version of a particular gene, occupying the same position on a specific chromosome as other alleles of that gene and differing from the others by only one or a few nucleotides. Each human cell contains two copies of each gene; these may be identical, or they may be two different alleles.

BRCA1/BRCA2. Breast cancer susceptibility genes. These two genes normally produce proteins involved in DNA repair. Mutations in these genes are associated in certain populations with a high risk for breast cancer and a significantly increased risk for ovarian cancer—with or without a family history of those disorders. Specific alleles of BRCA1 and BRCA2 genes have been associated with increased risk of developing breast (60% vs. 12% general population rate) and ovarian (15-40% vs. 1.4% general population rate) cancers. Together, BRCA1 and BRCA2 mutations account for between 5 and 10 percent of all breast cancers.

CDC. Centers for Disease Control and Prevention, Department of Health & Human Services.

CLIA. Clinical Laboratory Improvement Amendments of 1988.

CMS. Centers for Medicare and Medicaid Services, Department of Health & Human Services.

complex disorder. A disorder associated with a combination of alleles of several different genes—in contrast with Mendelian, single-gene, disorders. Because of the prevalence of many complex disorders in the general population, they are sometimes referred to as “common diseases.”

Suggested Citation:"Appendix A: Glossary Of Terms And Acronyms." Institute of Medicine and National Research Council. 2011. Direct-to-Consumer Genetic Testing: Summary of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/13021.
×

dominant. In an individual with two different alleles for a particular gene, the dominant allele determines the observed phenotype.

epigenetics. Changes in an organism’s phenotype by changes in gene expression that are not a result of the organism’s genome sequence.

FDCA. Food, Drug, and Cosmetic Act of 1938.

GINA. Genetic Information Nondiscrimination Act of 2008.

GWAS. Genome-wide association study.

genotype. An individual organism’s entire, exact genetic makeup, including all its alleles—regardless of whether or not those alleles are expressed.

HIPAA. Health Insurance Portability and Accountability Act of 1996.

haplotype. A set of alleles on a chromosome that tend to be inherited together.

HapMap. A haplotype map of a consensus human genome. The HapMap is a catalog of common genetic variants that occur in human beings. It describes what these variants are, where they occur in human DNA, and how they are distributed among people within populations and among populations in different parts of the world.

heterozygous. Having two different variations (alleles) of a DNA sequence.

highly penetrant. See penetrance.

homozygous. Having two identical alleles for a particular DNA sequence.

informed consent. An ethical and legal requirement in both clinical practice and in research with human participants that is necessary to ensure that an individual patient or client is aware of the risks and benefits of participating in research or of undergoing a clinical procedure. The individual must be informed of the nature of the procedure, possible alternatives, and any costs and potential risks as well as benefits.

LDT. Laboratory-developed test.

MDA. Medical Device Amendments of 1976.

Mendelian disorder. A disorder that has a strong association with a single gene. Also called a single-gene disorder.

Suggested Citation:"Appendix A: Glossary Of Terms And Acronyms." Institute of Medicine and National Research Council. 2011. Direct-to-Consumer Genetic Testing: Summary of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/13021.
×

NHGRI. National Human Genome Research Institute, an institute of the National Institutes of Health.

NICE: National Institute for Health and Clinical Excellence (United Kingdom).

nutrigenomics: The study of how dietary constituents interact with specific genes to affect health and risk of disease.

penetrance. Within the universe of individuals who carry a particular

allele, the proportion that actually express a phenotype associated with that allele.

phenotype. The observable physical characteristics of an organism, as determined by its genetic makeup, epigenetic modifications, and typically, by environmental influences.

recessive. The traits encoded by a recessive allele in a particular gene will only be physically apparent if it is present in both copies of the gene and cannot therefore be “over-ridden” by a dominant allele.

SACGHS. Secretary’s Advisory Committee on Genetics, Health, & Society. (Refers to the Secretary of Health & Human Services.)

SNP. Single-nucleotide polymorphism. A variation within a genome wherein a single nucleotide differs from the consensus genome.

Suggested Citation:"Appendix A: Glossary Of Terms And Acronyms." Institute of Medicine and National Research Council. 2011. Direct-to-Consumer Genetic Testing: Summary of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/13021.
×

This page intentionally left blank.

Suggested Citation:"Appendix A: Glossary Of Terms And Acronyms." Institute of Medicine and National Research Council. 2011. Direct-to-Consumer Genetic Testing: Summary of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/13021.
×
Page 43
Suggested Citation:"Appendix A: Glossary Of Terms And Acronyms." Institute of Medicine and National Research Council. 2011. Direct-to-Consumer Genetic Testing: Summary of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/13021.
×
Page 44
Suggested Citation:"Appendix A: Glossary Of Terms And Acronyms." Institute of Medicine and National Research Council. 2011. Direct-to-Consumer Genetic Testing: Summary of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/13021.
×
Page 45
Suggested Citation:"Appendix A: Glossary Of Terms And Acronyms." Institute of Medicine and National Research Council. 2011. Direct-to-Consumer Genetic Testing: Summary of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/13021.
×
Page 46
Next: Appendix B: Regulation of Direct-to-Consumer Genetic Testing Outside the United States »
Direct-to-Consumer Genetic Testing: Summary of a Workshop Get This Book
×
 Direct-to-Consumer Genetic Testing: Summary of a Workshop
Buy Paperback | $39.00 Buy Ebook | $31.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Today, scores of companies, primarily in the United States and Europe, are offering whole genome scanning services directly to the public. The proliferation of these companies and the services they offer demonstrate a public appetite for this information and where the future of genetics may be headed; they also demonstrate the need for serious discussion about the regulatory environment, patient privacy, and other policy implications of direct-to-consumer (DTC) genetic testing.

Rapid advances in genetic research already have begun to transform clinical practice and our understanding of disease progression. Existing research has revealed a genetic basis or component for numerous diseases, including Parkinson's disease, Alzheimer's disease, diabetes, heart disease, and several forms of cancer. The availability of the human genome sequence and the HapMap, plummeting costs of high-throughput screening, and increasingly sophisticated computational analyses have led to an explosion of discoveries of linkages between patterns of genetic variation and disease susceptibility. While this research is by no means a straight path toward better public health, improved knowledge of the genetic linkages has the potential to change fundamentally the way health professionals and public health practitioners approach the prevention and treatment of disease. Realizing this potential will require greater sophistication in the interpretation of genetic tests, new training for physicians and other diagnosticians, and new approaches to communicating findings to the public. As this rapidly growing field matures, all of these questions require attention from a variety of perspectives.

To discuss some of the foregoing issues, several units of the National Academies held a workshop on August 31 and September 1, 2009, to bring together a still-developing community of professionals from a variety of relevant disciplines, to educate the public and policy-makers about this emerging field, and to identify issues for future study. The meeting featured several invited presentations and discussions on the many technical, legal, policy, and ethical questions that such DTC testing raises, including: (1) overview of the current state of knowledge and the future research trajectory; (2) shared genes and emerging issues in privacy; (3) the regulatory framework; and (4) education of the public and the medical community.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!